Rhinovirus – From bench to bedside

Journal of the Formosan Medical Association

Volumn 116, Issue 7, 2017, Pages 496-504

  To, Kelvin K W ^a,b,c   Yip, Cyril C Y ^b   Yuen, Kwok Yung ^a,b,c  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c Research Centre of Infection and Immunology   (Hong Kong)

Author keywords

Antiviral; Asthma; Immune; Pneumonia; Rhinovirus; Vaccine

Indexed keywords

HOST FACTOR; HUMORAL ANTIBODY; INACTIVATED VIRUS VACCINE; ITRACONAZOLE; NICLOSAMIDE; PLECONARIL; RHINOVIRUS VACCINE; RUPINTRIVIR; UNCLASSIFIED DRUG; VIRAL PROTEIN; WIN 56921; VIRUS VACCINE;

ADAPTIVE IMMUNITY; ANTIVIRAL THERAPY; ASTHMA; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL RESEARCH; EPIDEMIC; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LOWER RESPIRATORY TRACT INFECTION; LUNG INFECTION; MORTALITY RATE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PATHOGENESIS; PHASE 3 CLINICAL TRIAL (TOPIC); PHYLOGENETIC TREE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHINOVIRUS; RHINOVIRUS INFECTION; SEROTYPE; TAXONOMY; UPPER RESPIRATORY TRACT INFECTION; VACCINATION; VIRUS ATTACHMENT; VIRUS GENOME; VIRUS REPLICATION; GENETICS; IMMUNOLOGY; PATHOGENICITY; PHYSIOLOGY; PICORNAVIRUS INFECTION;

ADAPTIVE IMMUNITY; GENOME, VIRAL; HUMANS; IMMUNITY, INNATE; PICORNAVIRIDAE INFECTIONS; RHINOVIRUS; VIRAL VACCINES; VIRUS REPLICATION;

EID: 85019014004     PISSN: 09296646     EISSN: 18760821     Source Type: Journal    
DOI: 10.1016/j.jfma.2017.04.009     Document Type: Review

References (101)

1. Atmar, R.L., Uncommon(ly considered) manifestations of infection with rhinovirus, agent of the common cold. Clin Infect Dis 41:2 (2005 Jul 15), 266–267.
2. To, K.K., Lau, S.K., Chan, K.H., Mok, K.Y., Luk, H.K., Yip, C.C., et al. Pulmonary and extrapulmonary complications of human rhinovirus infection in critically ill patients. J Clin Virol 77 (2016 Apr), 85–91.
3. Andries, K., Dewindt, B., Snoeks, J., Wouters, L., Moereels, H., Lewi, P.J., et al. Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity. J Virol 64:3 (1990 Mar), 1117–1123.
4. Blomqvist, S., Savolainen, C., Raman, L., Roivainen, M., Hovi, T., Human rhinovirus 87 and enterovirus 68 represent a unique serotype with rhinovirus and enterovirus features. J Clin Microbiol 40:11 (2002 Nov), 4218–4223.
5. Bochkov, Y.A., Grindle, K., Vang, F., Evans, M.D., Gern, J.E., Improved molecular typing assay for rhinovirus species A, B, and C. J Clin Microbiol 52:7 (2014 Jul), 2461–2471.
6. Savolainen-Kopra, C., Blomqvist, S., Smura, T., Roivainen, M., Hovi, T., Kiang, D., et al. 5' noncoding region alone does not unequivocally determine genetic type of human rhinovirus strains. J Clin Microbiol 47:4 (2009 Apr), 1278–1280.
7. Jacobs, S.E., Lamson, D.M., St George, K., Walsh, T.J., Human rhinoviruses. Clin Microbiol Rev 26:1 (2013 Jan), 135–162.
8. Jensen, L.M., Walker, E.J., Jans, D.A., Ghildyal, R., Proteases of human rhinovirus: role in infection. Methods Mol Biol 1221 (2015), 129–141.
9. Tam, J.C., Bidgood, S.R., McEwan, W.A., James, L.C., Intracellular sensing of complement C3 activates cell autonomous immunity. Science, 345(6201), 2014 Sep 5, 1256070.
10. Barral, P.M., Sarkar, D., Fisher, P.B., Racaniello, V.R., RIG-I is cleaved during picornavirus infection. Virology 391:2 (2009 Sep 1), 171–176.
11. Bochkov, Y.A., Watters, K., Ashraf, S., Griggs, T.F., Devries, M.K., Jackson, D.J., et al. Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication. Proc Natl Acad Sci U S A 112:17 (2015 Apr 28), 5485–5490.
12. Spickler, C., Lippens, J., Laberge, M.K., Desmeules, S., Bellavance, E., Garneau, M., et al. Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo. Antimicrob Agents Chemother 57:7 (2013 Jul), 3358–3368.
13. Mello, C., Aguayo, E., Rodriguez, M., Lee, G., Jordan, R., Cihlar, T., et al. Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C. Antimicrob Agents Chemother 58:3 (2014), 1546–1555.
14. Dorobantu, C.M., Ford-Siltz, L.A., Sittig, S.P., Lanke, K.H., Belov, G.A., van Kuppeveld, F.J., et al. GBF1- and ACBD3-independent recruitment of PI4KIIIbeta to replication sites by rhinovirus 3A proteins. J Virol 89:3 (2015 Feb), 1913–1918.
15. Chen, Y.H., Du, W., Hagemeijer, M.C., Takvorian, P.M., Pau, C., Cali, A., et al. Phosphatidylserine vesicles enable efficient en bloc transmission of enteroviruses. Cell 160:4 (2015 Feb 12), 619–630.
16. Bochkov, Y.A., Palmenberg, A.C., Lee, W.M., Rathe, J.A., Amineva, S.P., Sun, X., et al. Molecular modeling, organ culture and reverse genetics for a newly identified human rhinovirus C. Nat Med 17:5 (2011 May), 627–632.
17. Hao, W., Bernard, K., Patel, N., Ulbrandt, N., Feng, H., Svabek, C., et al. Infection and propagation of human rhinovirus C in human airway epithelial cells. J Virol 86:24 (2012 Dec), 13524–13532.
18. Papadopoulos, N.G., Sanderson, G., Hunter, J., Johnston, S.L., Rhinoviruses replicate effectively at lower airway temperatures. J Med Virol 58:1 (1999 May), 100–104.
19. Gwaltney, J.M. Jr., Rhinovirus infection of the normal human airway. Am J Respir Crit Care Med 152:4 Pt 2 (1995 Oct), S36–S39.
20. Papadopoulos, N.G., Bates, P.J., Bardin, P.G., Papi, A., Leir, S.H., Fraenkel, D.J., et al. Rhinoviruses infect the lower airways. J Infect Dis 181:6 (2000 Jun), 1875–1884.
21. Mosser, A.G., Vrtis, R., Burchell, L., Lee, W.M., Dick, C.R., Weisshaar, E., et al. Quantitative and qualitative analysis of rhinovirus infection in bronchial tissues. Am J Respir Crit Care Med 171:6 (2005 Mar 15), 645–651.
22. Tyrrell, D.A., Mika-Johnson, M., Phillips, G., Douglas, W.H., Chapple, P.J., Infection of cultured human type II pneumonocytes with certain respiratory viruses. Infect Immun 26:2 (1979 Nov), 621–629.
23. Tse, H., To, K.K., Wen, X., Chen, H., Chan, K.H., Tsoi, H.W., et al. Clinical and virological factors associated with viremia in pandemic influenza A/H1N1/2009 virus infection. PLoS One, 6(9), 2011, e22534.
24. To, K.K., Chan, K.H., Li, I.W., Tsang, T.Y., Tse, H., Chan, J.F., et al. Viral load in patients infected with pandemic H1N1 2009 influenza A virus. J Med Virol 82:1 (2010 Jan), 1–7.
25. Esposito, S., Daleno, C., Scala, A., Castellazzi, L., Terranova, L., Sferrazza Papa, S., et al. Impact of rhinovirus nasopharyngeal viral load and viremia on severity of respiratory infections in children. Eur J Clin Microbiol Infect Dis 33:1 (2014 Jan), 41–48.
26. Savolainen-Kopra, C., Simonen-Tikka, M.L., Klemola, P., Blomqvist, S., Suomenrinne, S., Nanto-Salonen, K., et al. Human rhinoviruses in INDIS-study material-evidence for recovery of viable rhinovirus from fecal specimens. J Med Virol 85:8 (2013 Aug), 1466–1472.
27. Lupo, J., Schuffenecker, I., Morel-Baccard, C., Bardet, J., Payen, V., Kaiser, L., et al. Disseminated rhinovirus C8 infection with infectious virus in blood and fatal outcome in a child with repeated episodes of bronchiolitis. J Clin Microbiol 53:5 (2015 May), 1775–1777.
28. Lau, S.K., Yip, C.C., Lung, D.C., Lee, P., Que, T.L., Lau, Y.L., et al. Detection of human rhinovirus C in fecal samples of children with gastroenteritis. J Clin Virol 53:4 (2012 Apr), 290–296.
29. Aab, A., Wirz, O., van de Veen, W., Sollner, S., Stanic, B., Ruckert, B., et al. Human rhinoviruses enter and induce proliferation of B lymphocytes. Allergy 72 (2017), 232–243, 10.1111/all.12931.
30. Winther, B., Gwaltney, J.M., Hendley, J.O., Respiratory virus infection of monolayer cultures of human nasal epithelial cells. Am Rev Respir Dis 141:4 Pt 1 (1990 Apr), 839–845.
31. Sajjan, U., Wang, Q., Zhao, Y., Gruenert, D.C., Hershenson, M.B., Rhinovirus disrupts the barrier function of polarized airway epithelial cells. Am J Respir Crit Care Med 178:12 (2008 Dec 15), 1271–1281.
32. Molyneaux, P.L., Mallia, P., Cox, M.J., Footitt, J., Willis-Owen, S.A., Homola, D., et al. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 188:10 (2013 Nov 15), 1224–1231.
33. Mallia, P., Footitt, J., Sotero, R., Jepson, A., Contoli, M., Trujillo-Torralbo, M.B., et al. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186:11 (2012 Dec 1), 1117–1124.
34. Jackson, D.J., Makrinioti, H., Rana, B.M., Shamji, B.W., Trujillo-Torralbo, M.B., Footitt, J., et al. IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med 190:12 (2014 Dec 15), 1373–1382.
35. Beale, J., Jayaraman, A., Jackson, D.J., Macintyre, J.D., Edwards, M.R., Walton, R.P., et al. Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci Transl Med, 6(256), 2014 Oct 1, 256ra134.
36. Graser, A., Ekici, A.B., Sopel, N., Melichar, V.O., Zimmermann, T., Papadopoulos, N.G., et al. Rhinovirus inhibits IL-17A and the downstream immune responses in allergic asthma. Mucosal Immunol 9:5 (2016 Sep), 1183–1192.
37. Mallia, P., Message, S.D., Gielen, V., Contoli, M., Gray, K., Kebadze, T., et al. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med 183:6 (2011 Mar 15), 734–742.
38. Jamieson, K.C., Warner, S.M., Leigh, R., Proud, D., Rhinovirus in the pathogenesis and clinical course of asthma. Chest 148:6 (2015 Dec), 1508–1516.
39. Royston, L., Tapparel, C., Rhinoviruses and respiratory enteroviruses: not as simple as ABC. Viruses, 8(1), 2016 Jan 11.
40. Hatchwell, L., Collison, A., Girkin, J., Parsons, K., Li, J., Zhang, J., et al. Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia. Thorax 70:9 (2015 Sep), 854–861.
41. Jackson, D.J., Glanville, N., Trujillo-Torralbo, M.B., Shamji, B.W., Del-Rosario, J., Mallia, P., et al. Interleukin-18 is associated with protection against rhinovirus-induced colds and asthma exacerbations. Clin Infect Dis 60:10 (2015 May 15), 1528–1531.
42. Schogler, A., Muster, R.J., Kieninger, E., Casaulta, C., Tapparel, C., Jung, A., et al. Vitamin D represses rhinovirus replication in cystic fibrosis cells by inducing LL-37. Eur Respir J 47:2 (2016 Feb), 520–530.
43. Zaas, A.K., Chen, M., Varkey, J., Veldman, T., Hero, A.O. 3rd, Lucas, J., et al. Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe 6:3 (2009 Sep 17), 207–217.
44. Vries, M., Bedke, N., Smithers, N.P., Loxham, M., Howarth, P.H., Nawijn, M.C., et al. Inhibition of Pim1 kinase, new therapeutic approach in virus-induced asthma exacerbations. Eur Respir J 47:3 (2016 Mar), 783–791.
45. To, K.K., Zhou, J., Chan, J.F., Yuen, K.Y., Host genes and influenza pathogenesis in humans: an emerging paradigm. Curr Opin Virol 14 (2015 Oct), 7–15.
46. Doyle, W.J., Casselbrant, M.L., Li-Korotky, H.S., Doyle, A.P., Lo, C.Y., Turner, R., et al. The interleukin 6 -174 C/C genotype predicts greater rhinovirus illness. J Infect Dis 201:2 (2010 Jan 15), 199–206.
47. Drysdale, S.B., Alcazar, M., Wilson, T., Smith, M., Zuckerman, M., Hodemaekers, H.M., et al. Functional and genetic predisposition to rhinovirus lower respiratory tract infections in prematurely born infants. Eur J Pediatr 175 (2016 Oct 1), 1943–1949, 10.1007/s00431-016-2780-0.
48. Helminen, M., Nuolivirta, K., Virta, M., Halkosalo, A., Korppi, M., Vesikari, T., et al. IL-10 gene polymorphism at -1082 A/G is associated with severe rhinovirus bronchiolitis in infants. Pediatr Pulmonol 43:4 (2008 Apr), 391–395.
49. Niespodziana, K., Cabauatan, C.R., Jackson, D.J., Gallerano, D., Trujillo-Torralbo, B., Del Rosario, A., et al. Rhinovirus-induced VP1-specific antibodies are group-specific and associated with severity of respiratory symptoms. EBioMedicine 2:1 (2015 Jan), 64–70.
50. Lau, S.K., Yip, C.C., Tsoi, H.W., Lee, R.A., So, L.Y., Lau, Y.L., et al. Clinical features and complete genome characterization of a distinct human rhinovirus (HRV) genetic cluster, probably representing a previously undetected HRV species, HRV-C, associated with acute respiratory illness in children. J Clin Microbiol 45:11 (2007 Nov), 3655–3664.
51. Muehling, L.M., Mai, D.T., Kwok, W.W., Heymann, P.W., Pomes, A., Woodfolk, J.A., Circulating memory CD4+ T cells target conserved epitopes of rhinovirus capsid proteins and respond rapidly to experimental infection in humans. J Immunol 197:8 (2016 Oct 15), 3214–3224.
52. Gaido, C.M., Stone, S., Chopra, A., Thomas, W.R., Le Souef, P.N., Hales, B.J., Immunodominant T-cell epitopes in the VP1 capsid protein of rhinovirus species A and C. J Virol 90 (2016 Sep 14), 10459–10471, 10.1128/JVI.01701-16.
53. Self, W.H., Williams, D.J., Zhu, Y., Ampofo, K., Pavia, A.T., Chappell, J.D., et al. Respiratory viral detection in children and adults: comparing asymptomatic controls and patients with community-acquired pneumonia. J Infect Dis 213:4 (2016 Feb 15), 584–591.
54. Schilder, A.G., Chonmaitree, T., Cripps, A.W., Rosenfeld, R.M., Casselbrant, M.L., Haggard, M.P., et al. Otitis media. Nat Rev Dis Primers, 2, 2016 Sep 08, 16063.
55. Petrocheilou, A., Tanou, K., Kalampouka, E., Malakasioti, G., Giannios, C., Kaditis, A.G., Viral croup: diagnosis and a treatment algorithm. Pediatr Pulmonol 49:5 (2014 May), 421–429.
56. Meissner, H.C., Viral bronchiolitis in children. N Engl J Med 374:1 (2016 Jan 7), 62–72.
57. Jain, S., Self, W.H., Wunderink, R.G., Fakhran, S., Balk, R., Bramley, A.M., et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 373:5 (2015 Jul 30), 415–427.
58. Jain, S., Williams, D.J., Arnold, S.R., Ampofo, K., Bramley, A.M., Reed, C., et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med 372:9 (2015 Feb 26), 835–845.
59. Choi, S.H., Huh, J.W., Hong, S.B., Lee, J.Y., Kim, S.H., Sung, H., et al. Clinical characteristics and outcomes of severe rhinovirus-associated pneumonia identified by bronchoscopic bronchoalveolar lavage in adults: comparison with severe influenza virus-associated pneumonia. J Clin Virol 62 (2015 Jan), 41–47.
60. Corne, J.M., Marshall, C., Smith, S., Schreiber, J., Sanderson, G., Holgate, S.T., et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 359:9309 (2002 Mar 9), 831–834.
61. Hai le, T., Bich, V.T., Ngai le, K., Diep, N.T., Phuc, P.H., Hung, V.P., et al. Fatal respiratory infections associated with rhinovirus outbreak, Vietnam. Emerg Infect Dis 18:11 (2012 Nov), 1886–1888.
62. Lau, S.K., Yip, C.C., Lin, A.W., Lee, R.A., So, L.Y., Lau, Y.L., et al. Clinical and molecular epidemiology of human rhinovirus C in children and adults in Hong Kong reveals a possible distinct human rhinovirus C subgroup. J Infect Dis 200:7 (2009 Oct 1), 1096–1103.
63. Piralla, A., Rovida, F., Campanini, G., Rognoni, V., Marchi, A., Locatelli, F., et al. Clinical severity and molecular typing of human rhinovirus C strains during a fall outbreak affecting hospitalized patients. J Clin Virol 45:4 (2009 Aug), 311–317.
64. Xiao, Q., Zheng, S., Zhou, L., Ren, L., Xie, X., Deng, Y., et al. Impact of human rhinovirus types and viral load on the severity of illness in hospitalized children with lower respiratory tract infections. Pediatr Infect Dis J 34:11 (2015 Nov), 1187–1192.
65. Chen, W.J., Arnold, J.C., Fairchok, M.P., Danaher, P.J., McDonough, E.A., Blair, P.J., et al. Epidemiologic, clinical, and virologic characteristics of human rhinovirus infection among otherwise healthy children and adults: rhinovirus among adults and children. J Clin Virol 64 (2015 Mar), 74–82.
66. McCulloch, D.J., Sears, M.H., Jacob, J.T., Lyon, G.M., Burd, E.M., Caliendo, A.M., et al. Severity of rhinovirus infection in hospitalized adults is unrelated to genotype. Am J Clin Pathol 142:2 (2014 Aug), 165–172.
67. Cheuk, D.K., Tang, I.W., Chan, K.H., Woo, P.C., Peiris, M.J., Chiu, S.S., Rhinovirus infection in hospitalized children in Hong Kong: a prospective study. Pediatr Infect Dis J 26:11 (2007 Nov), 995–1000.
68. Lee, W.M., Lemanske, R.F. Jr., Evans, M.D., Vang, F., Pappas, T., Gangnon, R., et al. Human rhinovirus species and season of infection determine illness severity. Am J Respir Crit Care Med 186:9 (2012 Nov 1), 886–891.
69. Foxman, E.F., Storer, J.A., Fitzgerald, M.E., Wasik, B.R., Hou, L., Zhao, H., et al. Temperature-dependent innate defense against the common cold virus limits viral replication at warm temperature in mouse airway cells. Proc Natl Acad Sci U S A 112:3 (2015 Jan 20), 827–832.
70. Reese, S.M., Thompson, M., Price, C.S., Young, H.L., Evidence of nosocomial transmission of human rhinovirus in a neonatal intensive care unit. Am J Infect Control 44:3 (2016 Mar 1), 355–357.
71. Mubareka, S., Louie, L., Wong, H., Granados, A., Chong, S., Luinstra, K., et al. Co-circulation of multiple genotypes of human rhinovirus during a large outbreak of respiratory illness in a veterans' long-term care home. J Clin Virol 58:2 (2013 Oct), 455–460.
72. Savolainen-Kopra, C., Korpela, T., Simonen-Tikka, M.L., Amiryousefi, A., Ziegler, T., Roivainen, M., et al. Single treatment with ethanol hand rub is ineffective against human rhinovirus–hand washing with soap and water removes the virus efficiently. J Med Virol 84:3 (2012 Mar), 543–547.
73. Winther, B., McCue, K., Ashe, K., Rubino, J.R., Hendley, J.O., Environmental contamination with rhinovirus and transfer to fingers of healthy individuals by daily life activity. J Med Virol 79:10 (2007 Oct), 1606–1610.
74. Chonmaitree, T., Alvarez-Fernandez, P., Jennings, K., Trujillo, R., Marom, T., Loeffelholz, M.J., et al. Symptomatic and asymptomatic respiratory viral infections in the first year of life: association with acute otitis media development. Clin Infect Dis 60:1 (2015 Jan 1), 1–9.
75. Cho, G.S., Moon, B.J., Lee, B.J., Gong, C.H., Kim, N.H., Kim, Y.S., et al. High rates of detection of respiratory viruses in the nasal washes and mucosae of patients with chronic rhinosinusitis. J Clin Microbiol 51:3 (2013 Mar), 979–984.
76. Miller, E.K., Gebretsadik, T., Carroll, K.N., Dupont, W.D., Mohamed, Y.A., Morin, L.L., et al. Viral etiologies of infant bronchiolitis, croup and upper respiratory illness during 4 consecutive years. Pediatr Infect Dis J 32:9 (2013 Sep), 950–955.
77. Spichak, T.V., Yatsyshina, S.B., Katosova, L.K., Kim, S.S., Korppi, M.O., Is the role of rhinoviruses as causative agents of pediatric community-acquired pneumonia over-estimated?. Eur J Pediatr 175 (2016 Oct 6), 1951–1958, 10.1007/s00431-016-2791-x.
78. Rhedin, S., Lindstrand, A., Hjelmgren, A., Ryd-Rinder, M., Ohrmalm, L., Tolfvenstam, T., et al. Respiratory viruses associated with community-acquired pneumonia in children: matched case-control study. Thorax 70:9 (2015 Sep), 847–853.
79. Shi, T., McLean, K., Campbell, H., Nair, H., Aetiological role of common respiratory viruses in acute lower respiratory infections in children under five years: a systematic review and meta-analysis. J Glob Health, 5(1), 2015 Jun, 010408.
80. Miller, E.K., Linder, J., Kraft, D., Johnson, M., Lu, P., Saville, B.R., et al. Hospitalizations and outpatient visits for rhinovirus-associated acute respiratory illness in adults. J Allergy Clin Immunol 137:3 (2016 Mar), 734–743 e1.
81. George, S.N., Garcha, D.S., Mackay, A.J., Patel, A.R., Singh, R., Sapsford, R.J., et al. Human rhinovirus infection during naturally occurring COPD exacerbations. Eur Respir J 44:1 (2014 Jul), 87–96.
82. Gao, Y.H., Guan, W.J., Xu, G., Lin, Z.Y., Tang, Y., Lin, Z.M., et al. The role of viral infection in pulmonary exacerbations of bronchiectasis in adults: a prospective study. Chest 147:6 (2015 Jun), 1635–1643.
83. Dijkema, J.S., van Ewijk, B.E., Wilbrink, B., Wolfs, T.F., Kimpen, J.L., van der Ent, C.K., Frequency and duration of rhinovirus infections in children with cystic fibrosis and healthy controls: a longitudinal cohort study. Pediatr Infect Dis J 35:4 (2016 Apr), 379–383.
84. Message, S.D., Laza-Stanca, V., Mallia, P., Parker, H.L., Zhu, J., Kebadze, T., et al. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci U S A 105:36 (2008 Sep 9), 13562–13567.
85. McLeish, N.J., Witteveldt, J., Clasper, L., McIntyre, C., McWilliam Leitch, E.C., Hardie, A., et al. Development and assay of RNA transcripts of enterovirus species A to D, rhinovirus species a to C, and human parechovirus: assessment of assay sensitivity and specificity of real-time screening and typing methods. J Clin Microbiol 50:9 (2012 Sep), 2910–2917.
86. Chen, J.H., Lam, H.Y., Yip, C.C., Wong, S.C., Chan, J.F., Ma, E.S., et al. Clinical evaluation of the new high-throughput luminex NxTAG respiratory pathogen panel assay for multiplex respiratory pathogen detection. J Clin Microbiol 54:7 (2016 Jul), 1820–1825.
87. Kim, H.K., Oh, S.H., Yun, K.A., Sung, H., Kim, M.N., Comparison of Anyplex II RV16 with the xTAG respiratory viral panel and Seeplex RV15 for detection of respiratory viruses. J Clin Microbiol 51:4 (2013 Apr), 1137–1141.
88. McAllister, S.C., Schleiss, M.R., Arbefeville, S., Steiner, M.E., Hanson, R.S., Pollock, C., et al. Epidemic 2014 enterovirus D68 cross-reacts with human rhinovirus on a respiratory molecular diagnostic platform. PLoS One, 10(3), 2015, e0118529.
89. Loeffelholz, M.J., Trujillo, R., Pyles, R.B., Miller, A.L., Alvarez-Fernandez, P., Pong, D.L., et al. Duration of rhinovirus shedding in the upper respiratory tract in the first year of life. Pediatrics 134:6 (2014 Dec), 1144–1150.
90. Hayden, F.G., Herrington, D.T., Coats, T.L., Kim, K., Cooper, E.C., Villano, S.A., et al. Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials. Clin Infect Dis 36:12 (2003 Jun 15), 1523–1532.
91. Schwitzer, G., How the media left the evidence out in the cold. BMJ 326 (2003), 1403–1404.
92. Hayden, F.G., Turner, R.B., Gwaltney, J.M., Chi-Burris, K., Gersten, M., Hsyu, P., et al. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. Antimicrob Agents Chemother 47:12 (2003 Dec), 3907–3916.
93. Binford, S.L., Weady, P.T., Maldonado, F., Brothers, M.A., Matthews, D.A., Patick, A.K., In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease. Antimicrob Agents Chemother 51:12 (2007 Dec), 4366–4373.
94. Strating, J.R., van der Linden, L., Albulescu, L., Bigay, J., Arita, M., Delang, L., et al. Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein. Cell Reports 10:4 (2015 Feb 3), 600–615.
95. Roulin, P.S., Lotzerich, M., Torta, F., Tanner, L.B., van Kuppeveld, F.J., Wenk, M.R., et al. Rhinovirus uses a phosphatidylinositol 4-phosphate/cholesterol counter-current for the formation of replication compartments at the ER-Golgi interface. Cell Host Microbe 16:5 (2014 Nov 12), 677–690.
96. Shim, A., Song, J.H., Kwon, B.E., Lee, J.J., Ahn, J.H., Kim, Y.J., et al. Therapeutic and prophylactic activity of itraconazole against human rhinovirus infection in a murine model. Sci Rep, 6, 2016 Mar 15, 23110.
97. Jurgeit, A., McDowell, R., Moese, S., Meldrum, E., Schwendener, R., Greber, U.F., Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects. PLoS Pathog, 8(10), 2012, e1002976.
98. Sridhar, S., Luk, H.K., Lau, S.K., Woo, P.C., First report of severe parainfluenza virus 4B and rhinovirus C coinfection in a liver transplant recipient treated with immunoglobulin. J Clin Virol 61:4 (2014 Dec), 611–614.
99. Mitchison, D.A., Prevention of colds by vaccination against a rhinovirus: a report by the scientific committee on common cold vaccines. Br Med J 1:5446 (1965 May 22), 1344–1349.
100. Lee, S., Nguyen, M.T., Currier, M.G., Jenkins, J.B., Strobert, E.A., Kajon, A.E., et al. A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques. Nat Commun, 7, 2016 Sep 22, 12838.
101. Glanville, N., McLean, G.R., Guy, B., Lecouturier, V., Berry, C., Girerd, Y., et al. Cross-serotype immunity induced by immunization with a conserved rhinovirus capsid protein. PLoS Pathog, 9(9), 2013, e1003669.